Kuala Lumpur: Biotechnology firm Biocon Ltd will start producing oral insulin commercially in early 2011, managing director Kiran Mazumdar- Shaw said in an interview in Kuala Lumpur on Tuesday. The product is in the third and final stage of clinical studies, she said.